Patents by Inventor Robert Croop

Robert Croop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTATIVE TREATMENT OF MIGRAINE
    Publication number: 20230321066
    Abstract: Disclosed are methods of for the preventative treatment of migraine, by administering to a patient in need thereof rimegepant or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising rimegepant and kits including the pharmaceutical compositions and instructions are also disclosed.
    Type: Application
    Filed: March 29, 2021
    Publication date: October 12, 2023
    Inventors: Robert CROOP, Vladimir CORIC
  • DUAL TREATMENT OF MIGRAINE
    Publication number: 20230285380
    Abstract: Disclosed is a method of treating migraine in a patient, wherein the method includes administering a CGRP antagonist that is effective for treating acute migraine and prevention of migraine. Also disclosed is a method of prevention of migraine in a patient, wherein the method includes administering a CGRP antagonist that is effective for prevention of migraine and treating acute migraine.
    Type: Application
    Filed: June 11, 2022
    Publication date: September 14, 2023
    Inventors: Vladimir CORIC, Charles M. CONWAY, Robert CROOP, Marianne FROST
  • ORAL FAST-DISPERSING DOSAGE FORM OF RIMEGEPANT
    Publication number: 20230108049
    Abstract: Provided is a fast-dispersing dosage form for oral delivery, wherein the fast-dispersing dosage form includes a rimegepant. Also provided is a method for delivering rimegepant to a subject, wherein the method includes orally administering to the subject a fast-dispersing dosage form including rimegepant.
    Type: Application
    Filed: February 26, 2021
    Publication date: April 6, 2023
    Inventors: Vladimir CORIC, Marianne FROST, Robert CROOP, Charles M. CONWAY
  • INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CGRP INHIBITORS
    Publication number: 20220401439
    Abstract: Provided is pharmaceutical composition for intranasal delivery, wherein the pharmaceutical composition includes a therapeutically active ingredient including a CGRP inhibitor. Also provided is a method for delivering a CGRP inhibitor to a subject, wherein the method includes intranasally administering to the subject a composition including a therapeutically active component including a CGRP inhibitor.
    Type: Application
    Filed: December 17, 2020
    Publication date: December 22, 2022
    Inventors: Vladimir CORIC, Charles M. CONWAY, Robert CROOP, Rajesh KUMAR
  • RIMEGEPANT FOR CGRP RELATED DISORDERS
    Publication number: 20220168295
    Abstract: Disclosed are methods of treating CGRP related disorders, e.g., migraine, by administering to a patient in need thereof rimegepant or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising rimegepant and kits including the pharmaceutical compositions and instructions are also disclosed.
    Type: Application
    Filed: August 8, 2021
    Publication date: June 2, 2022
    Inventors: Vladimir Coric, Robert Croop
  • CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH
    Publication number: 20210338654
    Abstract: Disclosed are methods of treating breakthrough migraine in patients using breakthrough CGRP antagonists. Also disclosed are methods for the prophylactic treatment of migraine.
    Type: Application
    Filed: January 19, 2020
    Publication date: November 4, 2021
    Inventors: Vladimir Coric, Robert Croop
  • Rimegepant for CGRP related disorders
    Patent number: 11083724
    Abstract: Disclosed are methods of treating CGRP related disorders, e.g., migraine, by administering to a patient in need thereof rimegepant or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising rimegepant and kits including the pharmaceutical compositions and instructions are also disclosed.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: August 10, 2021
    Assignee: Biohaven Pharmaceutical Ireland DAC
    Inventors: Vladimir Coric, Robert Croop
  • CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH
    Publication number: 20210196699
    Abstract: Disclosed are methods of treating breakthrough migraine in patients using breakthrough CGRP antagonists. Also disclosed are methods for the prophylactic treatment of migraine.
    Type: Application
    Filed: February 17, 2021
    Publication date: July 1, 2021
    Inventors: Vladimir Coric, Robert Croop
  • RIMEGEPANT FOR CGRP RELATED DISORDERS
    Publication number: 20210000814
    Abstract: Disclosed are methods of treating CGRP related disorders, e.g., migraine, by administering to a patient in need thereof rimegepant or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising rimegepant and kits including the pharmaceutical compositions and instructions are also disclosed.
    Type: Application
    Filed: March 25, 2019
    Publication date: January 7, 2021
    Inventors: Vladimir Coric, Robert Croop
  • RIMEGEPANT FOR CGRP RELATED DISORDERS
    Publication number: 20200383969
    Abstract: Disclosed are methods of treating CGRP related disorders, e.g., migraine, by administering to a patient in need thereof rimegepant or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising rimegepant and kits including the pharmaceutical compositions and instructions are also disclosed.
    Type: Application
    Filed: May 27, 2020
    Publication date: December 10, 2020
    Inventors: Vladimir Coric, Robert Croop